Unveiling the Discrepancy in Multiple Myeloma Risk Classification between Clinical Practice and SKY92 Test and the Impact on Survival

Biran, N., Dhakal, B., Niesvizky, R., Lentzsch, S., McKay, J. T., Vesole, D. H., Nooka, A. K., Paul, B., Hari, P. N., Stork-Sloots, L., D’Ambrosi, S., Kuiper, R., van Vliet, M., Siegel, D. S., Usmani, S. Z., & van Rhee, F. (2023). Unveiling the Discrepancy in Multiple Myeloma Risk Classification between Clinical Practice and SKY92 Test and the Impact on Survival. Blood, 142(Supplement 1), 2013–2013. https://doi.org/10.1182/blood-2023-181905
Authors:
Noa Biran
Binod Dhakal
Rubén Niesvizky
Suzanne Lentzsch
John T. McKay
David H. Vesole
Ajay K. Nooka
Barry Paul
Parameswaran Hari
Lisette Stork‐Sloots
Silvia D’Ambrosi
Rowan Kuiper
M. van Vliet
David S. Siegel
Saad Z. Usmani
Frits van Rhee
Affiliated Authors:
Rubén Niesvizky
Suzanne Lentzsch
Columbia Affiliation:
Subjects:
Diagnosis and Treatment of Multiple Myeloma (OpenAlex Topic)
Targeted Protein Degradation in Biomedical Research (OpenAlex Topic)
Computational Methods in Drug Discovery (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1182/blood-2023-181905
DOI:
10.1182/blood-2023-181905
Journal:
Blood
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: